Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease

Nephrol Dial Transplant. 2009 Apr;24(4):1082-8. doi: 10.1093/ndt/gfn601. Epub 2008 Nov 5.
No abstract available

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Anemia / physiopathology
  • Cardiovascular Diseases / complications
  • Chronic Disease
  • Erythropoietin / adverse effects
  • Erythropoietin / pharmacology
  • Erythropoietin / therapeutic use*
  • Hematinics / adverse effects
  • Hematinics / pharmacology
  • Hematinics / therapeutic use*
  • Humans
  • Kidney Diseases / complications*

Substances

  • Hematinics
  • Erythropoietin